The microbiological pattern of early onset neonatal sepsis (EONS) is different from late onset sepsis and is associated with several peri-natal risk factors. In view of the high mortality associated with this condition septic screening is carried out and empirical treatment with antibiotics started in the presence of two or more of these risk factors, resulting in a large number of babies receiving unnecessary antibiotics.[1] In order to identify these risk factors and the infective organisms so that empirical treatment with antibiotics could be more focused in our hospital, (a private sector teaching hospital providing level III care) a small case control study was carried out.The study group comprised of 32 consecutive babies with clinical features of sepsis and less than seven days of age and 60 randomly selected well babies discharged without any clinical evidence of sepsis during the same period formed the controls. Blood culture was sent for all babies and C reactive protein for 25 babies suspected to have sepsis. Other relevant investigations were done as needed.The incidence of EONS in the study period was 34/1000. A positive blood culture was obtained in 13 babies with sepsis (40.6%) which is similar to that reported by Kaushik and Rao [2][3] but lower than that observed by Tallur.[4] C reactive protein was positive (more than 8mg/dl) in 32% (8/25). The most common pathogen identified in our study was Klebsiella pneumoniae (6/13) which is similar to that reported by others.[3-5] However, group B streptococci and E. coli, which are common pathogens, causing early neonatal sepsis in the western countries were not seen in this study. Other organisms isolated were coagulase negative Staphylococcus (3/13), Pseudomonas spp (2/13), Micrococci spp (1/13) and A fecalis (1/13). The parameters considered for analysis of risk factors were antenatal care, birth order, birth weight, gestational age, gender, maternal fever, premature rupture of membranes (PROM), mode of delivery, birth asphyxia and meconium-stained liquor. Significant risk factors for EONS identified in this study by uni-variate analysis were pre-term and low birth weight babies, gravida less than or equal to two, maternal fever and PROM for more than 16 hours while multivariate analysis showed only pre-term delivery and PROM for more than16 hours to be significant risk factors which is similar to the observations of other investigators. [1,5] An interesting observation was that out of five mothers who had fever at the time of delivery, four had babies with a positive blood culture. Likewise, out of eight babies who had a positive CRP, six had a positive blood culture. However, this association between maternal fever, positive CRP and positive blood cultures is not statistically significant and needs a larger study to substantiate the observation.In conclusion, significant peri-natal risk factors for EONS, identified in this study, were prematurity and rupture of membranes more than 16 hours and the most common infective organism was Klebsiella pne...
Matrix metalloproteinases (MMPs) play an important role in breast cancer tumor invasion and progression. MMP-9 is a member of the MMP family and is also known as Gelatinase B or type IV collagenases (92 kDa) and possesses proteolytic activity against type IV collagen, a major component of the basement membrane. Our study aims to examine the association of Gelatinase B (-1562C > T) promoter polymorphism with breast cancer invasion and progression. The study involves 200 breast cancer patients and age-matched 191 healthy controls. The SNP-1562C > T (rs3918242) in MMP-9 promoter region was examined by allele-specific polymerase chain reaction and gel electrophoresis. The genotypes were determined and compared between patients and controls, and the influence of the polymorphism on clinicopathological data was analyzed. The T allele of the -1562C > T MMP-9 polymorphism was detected more frequently in breast cancer patients than controls (p < 0.001). Our results suggest the clinical importance of MMP-9 gene polymorphism (-1562C > T) in breast cancer patients. The study may also help in identifying individuals at risk of developing breast cancer.
Cardiovascular complications are the major cause of morbidity and mortality in diabetic patients. An attempt has been made to evaluate the risk factors for coronary heart disease in type II diabetics. In the present study the levels of fasting and postprandial plasma glucose, total cholesterol, low density lipoproteins, triglycerides were high and the levels of high density lipoproteins were low in the type II diabetics compared to controls. The markers of free radical induced injury i.e. malondialdehyde and nitrite/nitrate were high while total antioxidant status a marker for antioxidant protection against reactive oxygen specie,~ was low in diabetics compared to controls. The study therefore suggests the importance of assessing these markers of oxidative stress and antioxidant capacity along with the other routine investigations in diabetic patients for initiating antioxidant therapy in addition to primary and secondary preventive measures to mitigate the devastating consequences of diabetes leading to coronary heart disease.
We have established a strong association between FIGLA gene variants and POF in Indian women, which may be a potential genetic risk factor in the development of idiopathic POF. However, further independent genetic and functional studies are necessary to confirm our findings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.